Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis
Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis is a book. It was written by Marie Westwood and published by NIHR Journals Library in 2014.
Key facts
- author: Marie Westwood
- publication date: 2014
- book publisher: NIHR Journals Library
- book series: Health technology assessment
- book subjects: Cost effectiveness, Lungs-Cancer-Treatment
Extract data
Download datasets about Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis:
Dataset of books series that contain Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis:
Dataset of book subjects that contain Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis:
"Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis" is one of the books by Marie Westwood, books by NIHR Journals Library and 2,617,384 books in our database.
Related
Connected or similar to Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis: .
This dashboard is based on data from: The British Library.
This content is available under the CC BY 4.0 license.